Cancer Care Ontario | Cancer Care Ontario

Use of Amifostine to Ameliorate the Toxic Effects of Chemotherapy in the Treatment of Cancer

Systemic therapy for the treatment of adult patients with lower-risk myelodysplastic syndromes

Use of Continuous Infusion Pumps During Radiation Treatment: Recommendation Report (March 2012)

The Role of Aromatase Inhibitors in the Treatment of Postmenopausal Women with Metastatic Breast Cancer

Dasatinib for the Treatment of Imatinib-Resistant or -Intolerant Chronic Myeloid Leukemia

Safe Administration of Systemic Cancer Therapy Part 2: Administration of Systemic Treatment and Management of Preventable Adverse Events

A Pan-Canadian Practice Guideline: Prevention, Screening, Assessment and Treatment of Sleep Disturbances in Adults with Cancer

Endorsement of the 2018 American Society of Clinical Oncology Treatment of Malignant Pleural Mesothelioma Guideline

The Role of Primary Tumour Location in the Selection of Biologics for the Treatment of Unresectable Metastatic Colorectal Cancer: An Endorsement of a Canadian Consensus Statement

Cancer Care Ontario Bladder Cancer Guideline: An Endorsement of the 2017 American Urological Association Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA, ASCO, ASTRO, SUO Guide